Eli Lilly (NYSE: LLY) director defers fees into 13.878 stock units

Rhea-AI Filing Summary

LUCIANO JUAN R reported acquisition or exercise transactions in this Form 4 filing.

ELI LILLY & Co director Juan R Luciano received a grant of 13.878 shares of common stock on 2026-07-20 at $1,146.9000 per share. These shares were deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in common shares after his separation from service. Following this award, he directly holds 16,904.5921 shares.

Insider Trade Summary

Net Buyer: 13.878 shares

Net Buy 1 txn

Insider LUCIANO JUAN R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	13.878	$1,146.90	$16K

Holdings After Transaction: Common Stock — 16,904.5921 shares (Direct)

Footnotes (1)

1. F1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Key Figures

Shares acquired: 13.878 shares Grant price per share: 1146.9000 per share Holdings after transaction: 16904.5921 shares

3 metrics

Shares acquired 13.878 shares Grant, award, or other acquisition of common stock on 2026-07-20

Grant price per share 1146.9000 per share Implied value of common stock award taken in lieu of cash compensation

Holdings after transaction 16904.5921 shares Total direct common stock holdings following the award

Key Terms

Lilly Directors' Deferral Plan, stock units, deferred in lieu of cash compensation, separation from service

4 terms

Lilly Directors' Deferral Plan financial

"as stock units under the Lilly Directors' Deferral Plan and will be settled"

stock units financial

"deferred in lieu of cash compensation as stock units under the Lilly"

Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.

deferred in lieu of cash compensation financial

"shares acquired pursuant to this filing have been deferred in lieu of cash compensation"

separation from service financial

"will be settled in shares of common stock following the reporting person's separation from service"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/21/2026 - 04:40 PM Accepted by SEC EDGAR 07/21/2026 - 04:39 PM Learn about SEC filing dates

FAQ

What insider transaction did Eli Lilly (LLY) director Juan R Luciano report?

Juan R Luciano reported a grant of 13.878 shares of Eli Lilly common stock on 2026-07-20. The award was taken in stock units instead of cash director compensation under the company’s directors’ deferral plan.

At what price was Juan R Luciano’s Eli Lilly (LLY) stock award valued?

The stock award was valued at $1,146.9000 per share. This reflects the value of director compensation Luciano elected to defer into stock units rather than receive in cash, under the Lilly Directors' Deferral Plan.

How many Eli Lilly (LLY) shares does Juan R Luciano hold after this transaction?

After the reported award, Juan R Luciano directly holds 16,904.5921 shares of Eli Lilly common stock. This figure includes the newly granted 13.878 shares that were deferred as stock units under the director deferral program.

What is the Lilly Directors' Deferral Plan mentioned in the Eli Lilly (LLY) filing?

The Lilly Directors' Deferral Plan allows directors to defer cash compensation into stock units tied to Eli Lilly common stock. These units are later settled in actual shares of common stock after the director’s separation from service.

When will Juan R Luciano’s deferred Eli Lilly (LLY) stock units be settled?

The stock units from this award will be settled in common shares after Juan R Luciano’s separation from service. Until then, the units represent deferred compensation under the Lilly Directors' Deferral Plan rather than immediately delivered shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LUCIANO JUAN R

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS INDIANA 46285

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/20/2026		A		13.878(1)	A	$1,146.9	16,904.5921	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Remarks:

	/s/ Jonathan Groff for Juan R. Luciano, pursuant to authorization on file	07/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)